Five OTC Markets Issuers Uplisted to Nasdaq in March 2018
Five issuers uplisted from the OTC Markets to the Nasdaq in March 2018. Zero issuers uplisted to the NYSE or NYSE American last month. Learn more about March’s OTC ‘graduates’ below.
Cocrystal Pharma, Inc. (Nasdaq: COCP)
On March 12, 2018, COCP uplisted from the OTCQB to the Nasdaq Capital Market. Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses.
Orgenesis, Inc. (Nasdaq: ORGS)
On March 13, 2018, ORGS uplisted from the OTCQB to the Nasdaq Capital Market. Orgenesis is a vertically-integrated biopharmaceutical company with expertise and unique experience in cell therapy development and manufacturing.
SIGA Technologies, Inc. (Nasdaq: SIGA)
On March 22, 2018, SIGA uplisted from the OTCPINK to the Nasdaq Global Market. SIGA Technologies, Inc. is a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats.
OP Bancorp (Nasdaq: OPBK)
On March 28, 2018, OPBK uplisted from the OTCPINK to the Nasdaq Global Market. OP Bancorp, is engaged in the general commercial banking business in Los Angeles and Orange Counties and is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities.
In connection with the uplist, OPBK completed a public offering of 2,000,000 shares of common stock at a price of $11.00 per share for a total offering size of $22,000,000. Keefe, Bruyette & Woods, Inc., A Stifel Company, acted as book-running manager and D.A Davidson & Co. acted as a co-manager for the offering.
VirTra, Inc. (Nasdaq: VTSI)
On March 29, 2018, VTSI uplisted from the OTCQX to the Nasdaq Capital Market. VirTra is a global provider of training simulators for the law enforcement, military, educational and commercial markets.